Evren Technologies is a clinical-stage medical device company developing a non-invasive approach to treating post-traumatic stress disorder (PTSD). Its Phoenix technology delivers electrical stimulation through the ear to activate the vagus nerve, with the aim of helping regulate the body’s stress response and reduce PTSD symptoms. The company is seeking investment to advance clinical trials and bring its technology to market.
13 million Americans live with PTSD each year, and many still struggle to find relief. Evren is targeting this substantial unmet need with a drug-free, non-invasive device designed to expand the treatment options available to patients.
13 million Americans live with PTSD each year, and many still struggle to find relief. Evren is targeting this substantial unmet need with a drug-free, non-invasive device designed to expand the treatment options available to patients.
13 million Americans live with PTSD each year, and many still struggle to find relief. Evren is targeting this substantial unmet need with a drug-free, non-invasive device designed to expand the treatment options available to patients.
Register Here to
View Pitch Deck
“It’s not a drug that I’m putting in my system, and it’s not something that I’m smoking. So if you’re telling me that you can put something in my ear and make me better, sign me up every day of the week.”
The Team
Rick Giancola
Founder, Chairman of the Board & General Counsel
A life sciences executive with more than 35 years of experience. Rick has led international growth at Cochlear Americas and Nurotron Biotechnology and served as CEO of Neuromonics, bringing experience across medical device commercialization, clinical activities and regulatory operations.
Weaver Gaines
Founder, Chairman of the Board & General Counsel
A life sciences entrepreneur with more than 40 years of management and legal experience. Weaver co-founded and led OBMedical, which secured FDA clearance for an electronic maternal-fetal monitor before being acquired by Philips Healthcare in 2018.
Neil Euliano, PhD
Chief Technology Officer
A medical device developer with more than 40 U.S. patents who has helped secure FDA clearance for more than six devices. Neil co-founded two companies that achieved commercial sales and acquisition, and served as CTO of OBMedical when Philips Healthcare acquired it.
Register Here to
View Pitch Deck
Register Here to
View Pitch Deck
Interested in Investing in Healthcare Innovation?
